SCHEMBL6709451

SCHEMBL6709451

CC(C[CH]c1cccc2ccccc12)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD2 O60906 2/20 0.53
GRIK1 P39086 1/20 0.48
GRIK2 Q13002 1/20 0.48
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.46
F2 P00734 1/20 0.46
LMNA P02545 1/20 0.46
MTNR1A P48039 1/20 0.44
MTNR1B P49286 1/20 0.44
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
TDP1 Q9NUW8 1/20 0.40
PPARG P37231 2/20 0.40
PPARA Q07869 2/20 0.40
MME P08473 1/20 0.40
ACE P12821 1/20 0.40
CPA1 P15085 1/20 0.40
ACE2 Q9BYF1 1/20 0.40
AKR1B1 P15121 1/20 0.40
NR4A1 P22736 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4817482 0.80 SMPD2 (0.43) SMPD2KDM4EALDH1A1F2LMNA
SCHEMBL9859576 0.78 SMPD2 (0.43) SMPD2GRIK1GRIK2KDM4EALDH1A1
SCHEMBL6028188 0.77 SMPD2 (0.41) SMPD2GRIK1GRIK2KDM4EALDH1A1
SCHEMBL27544275 0.76 SMPD2 (0.40) SMPD2GRIK1GRIK2KDM4EALDH1A1
SCHEMBL5254370 0.74 RXRA (0.41) SMPD2GRIK1GRIK2KDM4EALDH1A1
Alanine SCHEMBL1942247 0.73 SMPD2 (0.51) SMPD2GRIK1GRIK2KDM4EALDH1A1
SCHEMBL6907446 0.72 CTNNB1 (0.59) KDM4EALDH1A1TDP1MMEACE
SCHEMBL16017641 0.72 CTNNB1 (0.59) KDM4EALDH1A1TDP1MMEACE
SCHEMBL25846959 0.72 CTNNB1 (0.59) KDM4EALDH1A1TDP1MMEACE
SCHEMBL12892302 0.72 ALDH1A1 (0.49) SMPD2GRIK1GRIK2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392315-A1 METHODS OF TREATING ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-03-03 EP disclosed
WO-2002100410-A1 METHODS OF TREATING ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed